Bertolini Mark T 4
4 · Oscar Health, Inc. · Filed Jun 29, 2026
Research Summary
AI-generated summary of this filing
Oscar Health (OSCR) CEO Mark Bertolini Sells Shares
What Happened
- Mark T. Bertolini, CEO of Oscar Health (OSCR), disposed of a total of 1,206,310 shares in open-market sales on June 25–26, 2026. Transactions reported:
- 597,942 shares at a weighted-average $28.60 — $17,101,141
- 17,200 shares at $29.08 — $500,176
- 441,373 shares at $29.11 — $12,848,368
- 149,795 shares at $29.79 — $4,462,393
- Total proceeds approximately $34.9 million.
- These were sales (code S) — typically routine dispositions rather than purchases that signal bullishness.
Key Details
- Dates: June 25–26, 2026. Filing date: June 29, 2026 (Form 4 accession 0001352552-26-000010).
- Price details: reported prices are weighted averages; the filing provides ranges for the multiple transactions (approx. $28.06–$30.17 across trades). The filer will supply per‑price breakdown on request.
- Purpose/footnotes: Sales were effected to satisfy tax-withholding obligations in connection with deferred settlement of performance stock units (PSUs) and time-based restricted stock units (RSUs) that vested April 3, 2026, and were executed pursuant to a Rule 10b5‑1 instruction (entered Nov 10, 2025; amended Mar 24, 2026).
- Shares owned after the transactions are not provided in the data you supplied.
- Timeliness: Form 4 was filed June 29, 2026; the filing appears consistent with Form 4 timing requirements for these transaction dates.
Context
- These sales were tax-withholding related and executed under a pre-existing 10b5‑1 plan — such transactions are typically administrative (to cover taxes on vested awards) rather than an investor signal of conviction.
- No option exercises, gifts, or purchases were reported in this filing.
Insider Transaction Report
Form 4
Bertolini Mark T
DirectorChief Executive Officer
Transactions
- Sale
Class A Common Stock
[F1][F2][F3]2026-06-25$28.60/sh−597,942$17,101,141→ 9,598,934 total - Sale
Class A Common Stock
[F1][F4][F3]2026-06-25$29.08/sh−17,200$500,176→ 9,581,734 total - Sale
Class A Common Stock
[F1][F5][F3]2026-06-26$29.11/sh−441,373$12,848,368→ 9,140,361 total - Sale
Class A Common Stock
[F1][F6][F3]2026-06-26$29.79/sh−149,795$4,462,393→ 8,990,566 total
Footnotes (6)
- [F1]Represents sale of shares to satisfy tax withholding obligations in connection with the deferred settlement of performance stock units and time-based restricted stock units that vested on April 3, 2026. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on November 10, 2025 and amended and restated on March 24, 2026.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.06 to $29.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F3]Includes shares to be issued in connection with the vesting of one or more restricted stock units.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.06 to $29.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.51 to $29.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.51 to $30.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Signature
/s/ Melissa Curtin, Attorney-in-Fact|2026-06-29